Verdinexor: A Novel Oral Therapy for Canine Lymphoma
|Event Date||Dec 15, 2022 6:30 pm|
|Registration Start Date||Nov 29, 2022 12:00 pm|
|Cut off date||Dec 12, 2022 11:00 pm|
|Location||Redstone American Grill|
Veterinarians, Technicians, and Practice Managers are all invited to Redstone American Grill in Minnetonka, MN, for an evening with Kathy Engler, Professional Services Veterinarian on behalf of Dechra Veterinary Products. Food & non-alcoholic beverages will be provided and attendees will earn 1 RACE-Approved Credit Hour.
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
Check-in begins at 6:30 pm. The presentation will start at 7 pm.
For assistance or questions, please contact: